PUBLIC CONTRACT · 2024
EXCL SPMS (2021/006) Med Foro Onc e Imun - Vários
- Contract value
- €315,859.28
- Signed on
- 18 January 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10767341PUBLISHED SUBJECT
EXCL SPMS (2021/006) Med Foro Onc e Imun - Vários
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Coimbra, Coimbra
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Lilly Portugal · Tax ID 500165602
- Bidder
- AMGEN BIOFARMACÊUTICA, LDA. · Tax ID 502942959
- Bidder
- TAKEDA FARMACEUTICA PORTUGAL · Tax ID 502801204
- Bidder
- ABBVIE,LDA · Tax ID 510229050
- Bidder
- GILEAD SCIENCES, LDA. · Tax ID 503604704
- Bidder
- MERCK FARMA E QUIMICA, S.A. · Tax ID 500650870
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €315,859.28
- Procedure base price
- €1,137,389.47
- Total effective price
- Not reported on Portal BASE
- Publication date
- 14 June 2024
- Award date
- 18 January 2024
- Signing date
- 18 January 2024
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7090313
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.